Merit Medical Systems Pre-Paid Expenses 2010-2024 | MMSI

Merit Medical Systems pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • Merit Medical Systems pre-paid expenses for the quarter ending December 31, 2024 were $0.029B, a 17.53% increase year-over-year.
  • Merit Medical Systems pre-paid expenses for 2024 were $0.029B, a 17.53% increase from 2023.
  • Merit Medical Systems pre-paid expenses for 2023 were $0.024B, a 8.79% increase from 2022.
  • Merit Medical Systems pre-paid expenses for 2022 were $0.022B, a 38.24% increase from 2021.
Merit Medical Systems Annual Pre-Paid Expenses
(Millions of US $)
2024 $29
2023 $24
2022 $22
2021 $16
2020 $13
2019 $12
2018 $11
2017 $9
2016 $6
2015 $6
2014 $5
2013 $5
2012 $4
2011 $4
2010 $2
2009 $1
Merit Medical Systems Quarterly Pre-Paid Expenses
(Millions of US $)
2024-12-31 $29
2024-09-30 $27
2024-06-30 $26
2024-03-31 $24
2023-12-31 $24
2023-09-30 $28
2023-06-30 $25
2023-03-31 $20
2022-12-31 $22
2022-09-30 $27
2022-06-30 $23
2022-03-31 $20
2021-12-31 $16
2021-09-30 $19
2021-06-30 $17
2021-03-31 $14
2020-12-31 $13
2020-09-30 $16
2020-06-30 $14
2020-03-31 $16
2019-12-31 $12
2019-09-30 $18
2019-06-30 $12
2019-03-31 $11
2018-12-31 $11
2018-09-30 $12
2018-06-30 $12
2018-03-31 $10
2017-12-31 $9
2017-09-30 $21
2017-06-30 $9
2017-03-31 $8
2016-12-31 $6
2016-09-30 $7
2016-06-30 $8
2016-03-31 $6
2015-12-31 $6
2015-09-30 $5
2015-06-30 $6
2015-03-31 $5
2014-12-31 $5
2014-09-30 $6
2014-06-30 $5
2014-03-31 $6
2013-12-31 $5
2013-09-30 $5
2013-06-30 $5
2013-03-31 $5
2012-12-31 $4
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $4
2011-09-30 $4
2011-06-30 $4
2011-03-31 $4
2010-12-31 $2
2010-09-30 $3
2010-06-30 $3
2010-03-31 $2
2009-12-31 $1
2009-09-30 $2
2009-06-30 $2
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $6.033B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47